Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Dynavax Technologies Corporation (DVAX)

Pharmaceutical Preparations

https://www.dynavax.com

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

2100 POWELL STREET, SUITE 720
EMERYVILLE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/19/2004

Market Cap

1,472,279,340

Shares Outstanding

129,259,999

Weighted SO

129,260,850

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

ALKS --.--%

NBIX --.--%

ITCI --.--%

DCPH --.--%

AQST --.--%

AMPH --.--%

LNTH --.--%

ANIP --.--%

IRWD --.--%

Beta

1.2760

Last Div

0.0000

Range

9.74-15.15

Chg

-0.1050

Avg Vol

2257672

Mkt Cap

1472279340

Exch

NASDAQ

Country

US

Phone

510 848 5100

DCF Diff

7.3995

DCF

19.2395

Div Yield

0.0000

P/S

5.8963

EV Multiple

117.6471

P/FV

2.2880

Div Yield %

0.0000

P/E

85.6285

PEG

2.6598

Payout

0.0000

Current Ratio

14.1821

Quick Ratio

13.1777

Cash Ratio

1.8089

DSO

91.5515

DIO

508.1154

Op Cycle

599.6669

DPO

37.0540

CCC

562.6129

Gross Margin

0.8203

Op Margin

-0.0556

Pretax Margin

0.0743

Net Margin

0.0688

Eff Tax Rate

0.0741

ROA

0.0169

ROE

0.0276

ROCE

-0.0146

NI/EBT

0.9259

EBT/EBIT

-1.3351

EBIT/Rev

-0.0556

Debt Ratio

0.2241

D/E

0.3544

LT Debt/Cap

0.2578

Total Debt/Cap

0.2617

Int Coverage

-3.5338

CF/Debt

0.1709

Equity Multi

1.5810

Rec Turnover

3.9868

Pay Turnover

9.8505

Inv Turnover

0.7183

FA Turnover

4.2588

Asset Turnover

0.2457

OCF/Share

0.2974

FCF/Share

0.2699

Cash/Share

5.6190

OCF/Sales

0.1559

FCF/OCF

0.9076

CF Coverage

0.1709

ST Coverage

8.5822

CapEx Coverage

10.8196

Div&CapEx Cov

10.8196

P/BV

2.2880

P/B

2.2880

P/S

5.8963

P/E

85.6285

P/FCF

41.6710

P/OCF

37.7827

P/CF

37.7827

PEG

2.6598

P/S

5.8963

EV Multiple

117.6471

P/FV

2.2880

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks Zacks Investment Research Dec 29, 11:45 Bayer (BAYRY) Loses 28% in 2023: What to Expect in 2024? MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts MarketWatch Dec 26, 12:18 20 favorite small-cap stocks for 2024 among Wall Street analysts Zacks Investment Research Nov 24, 14:05 Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How Zacks Investment Research Nov 24, 14:05 Kiniksa Pharmaceuticals (KNSA) Up 14.7% YTD: Here's How

Revenue Product Segmentation